Cargando…
Nano-sized carriers in gene therapy for peritoneal fibrosis in vivo
Peritoneal fibrosis is a crucial complication in patients receiving peritoneal dialysis. It is a major pathological feature of peritoneal membrane failure, which leads to withdrawal of peritoneal dialysis. No specific therapy has yet been established for the treatment of peritoneal fibrosis. However...
Autores principales: | Igarashi, Yusuke, Hoshino, Taro, Ookawara, Susumu, Ishibashi, Kenichi, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167028/ https://www.ncbi.nlm.nih.gov/pubmed/30410706 http://dx.doi.org/10.1080/20022727.2017.1331100 |
Ejemplares similares
-
Nano-sized carriers in gene therapy for renal fibrosis in vivo
por: Miyazawa, Haruhisa, et al.
Publicado: (2017) -
Transgene and islet cell delivery systems using nano-sized carriers for the treatment of diabetes mellitus
por: Ito, Kiyonori, et al.
Publicado: (2017) -
The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis
por: Igarashi, Yusuke, et al.
Publicado: (2017) -
miR−122−5p Regulates Renal Fibrosis In Vivo
por: Kaneko, Shohei, et al.
Publicado: (2022) -
Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study
por: Kaneko, Shohei, et al.
Publicado: (2022)